RUNX1 and neoplasm: To assess the efficacy of RUNX1-IT1 on the tumorigenicity of HCC cells in vivo, Lenti-RUNX1-IT1 and Lenti-vector MHCC-97H cells were subcutaneously injected into the flanks of nude mice to establish a xenograft tumour model.